Specialty Endocrinology
-
Featured
Mass General Researchers Develop New Oral Compound for Osteoporosis Prevention and Treatment
Massachusetts General Hospital researchers have identified a new compound that increased bone formation and bone mass when given orally to mice. Their findings may lead to a new, more convenient therapy for the prevention and treatment of osteoporosis.
-
In Utero Exposure to SARS-CoV-2 May Increase the Risk of Cardiometabolic Disease
Massachusetts General Hospital researchers found that infants who have in utero exposure to maternal SARS-CoV-2 exhibit lower birth weight followed by accelerated weight gain in the first year of life, a pattern thought to increase the risk of obesity and cardiometabolic disease in childhood and adulthood.
-
After Denosumab Discontinuation, Alendronate Superior to Raloxifene at Maintaining BMD Gains
Massachusetts General Hospital researchers found that for postmenopausal women with osteoporosis who discontinue short-term denosumab treatment and are unable or unwilling to transition to a bisphosphonate, raloxifene may be a suitable alternative, although inferior in maintaining the gain in bone mineral density.
-
Psychological and Behavioral Factors Identified That Predict Success of Lifestyle Interventions for Weight Loss
Massachusetts General Hospital researchers identified improvements in autonomous motivation, dietary self-regulation, and low-fat diet as the most important predictors of weight loss during a two-year lifestyle intervention, but only improvements in low-fat diet and depression were important after a year of follow-up.
-
Targeted Therapy for BRAF Mutation in Craniopharyngioma
A new targeted therapy for brain tumors shrinks craniopharyngiomas by 91% and helps patients avoid long-term complications of surgery and radiation.
-
Pathways Case Record: POEMS Disease
The Pathways Service investigated a 65-year-old woman admitted with recurrent fluid buildup in the abdomen and a history of IgA lambda gammopathy, neuropathy, leg swelling, hypothyroidism, and more. She was diagnosed with POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, Skin changes) syndrome.
Endocrinology Contributors
-
Camille E. Powe, MD
Endocrinologist, Massachusetts General Hospital, Co-Director, Diabetes in Pregnancy Program
Recent Article
Carbohydrate Intake Before Oral Glucose Tolerance Test May Prevent Accurate Diagnosis of Gestational Diabetes -
Elizabeth A. Lawson, MD
Clinician, Neuroendocrine Unit, Division of Endocrinology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School
Recent Article
Cholecystokinin Elevation Observed in Youth With Avoidant/Restrictive Food Intake Disorder -
Joel S. Finkelstein, MD
Endocrinologist, Massachusetts General Hospital, Associate Director, Bone Density Center, Endocrine Unit, Massachusetts General Hospital
Recent Article
Ivacaftor Improves Skeletal Outcomes in Patients with Cystic Fibrosis -
Jose C. Florez, MD, PhD
Chief, Diabetes Unit, Endocrine Division, John T. Potts Jr., MD Endowed Chair in Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Newly Identified Genetic Variant Has Substantial Effect on Risk of Type 2 Diabetes -
Melissa S. Putman, MD
Endocrinologist, Massachusetts General Hospital, Assistant Professor of Pediatrics, Harvard Medical School
Recent Article
Continuous Glucose Monitoring Shows Promise for Diagnosis of Cystic Fibrosis–Related Diabetes -
Steven Kyle Grinspoon, MD
Chief, Metabolism Unit, Massachusetts General Hospital, Director, Nutrition Obesity Research Center, Harvard
Recent Article
Diet Quality Is Suboptimal or Poor in Large Proportion of Global Population With HIV